Cover storyPharma’s Next Operating Model: Governed Intelligence, Not Automation for Its Own Sake
Explore how pharma leaders can build governed AI systems that improve manufacturing without compromising quality or accountability.
Cover storyExplore how pharma leaders can build governed AI systems that improve manufacturing without compromising quality or accountability.

AbbVie's Phase 2a dual-targeting Crohn's trial shows higher remission rates, raising bioprocessing and analytical complexity questions for manufacturing teams.

Dr. Reddy's secures DCGI approval for Zytorvi in advanced esophageal cancer, expanding beyond its original NPC indication.

Achieve Life Sciences' ORCA-OL trial shows 39% quit rate at 52 weeks in placebo-prior patients, raising CMC and NDA readiness questions.

AstraZeneca and Oracle partner on AI to cut clinical trial delays, with downstream implications for CMC timelines and regulatory submissions.
Latest edition
SPONSORED
SPONSORED
SPONSORED
Oct 28
Nov 28From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.








Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.

